http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2234327-C2

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
filingDate 2002-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0669240e692e6de073c686b86bb30a49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37338d18f8648e66d757eeafab0ecb01
publicationDate 2004-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2234327-C2
titleOfInvention Method for treatment of pain syndrome in oncological patients
abstract FIELD: medicine, oncology, pharmacy. n SUBSTANCE: invention can be used in treatment of pain syndrome in oncological incurable patients in post-operative period. Method involves application of narcotic analgetics. Autoplasma taken in the amount 100 ml is incubated with narcotic analgetic remedy: 1% morphine or 2% omnoponum in one-half dose - 0.5-1 ml at t = 37 C for 30 min followed by administration by intravenous drop route. Method provides elongation time of analgetic effect, to reduce expression of adverse effects of narcotic analgetics and to improved quality life of patients. n EFFECT: improved method for treatment. n 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2791085-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-3503-G2
priorityDate 2002-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288826

Total number of triples: 19.